| Literature DB >> 33928434 |
Kai Zhang1,2,3,4, Qi-Wen Guan1,2,3,4, Xin-Yu Zhou5, Qin-Xuan Xia1,2,3,4, Xi-Xi Yin6, Hong-Hao Zhou1,2,3,4, Xiao-Yuan Mao7,8,9,10.
Abstract
Connexins (Cxs) are ubiquitous transmembrane proteins that possess both channel function (e.g., formations of gap junction and hemichannel) and non-channel properties (e.g., gene transcription and protein-protein interaction). Several factors have been identified to play a role in the regulation of Cxs, which include those acting intracellularly, as redox potential, pH, intramolecular interactions, and post-translational modifications (e.g., phosphorylation, S-nitrosylation) as well as those acting extracellularly, such as Ca2+ and Mg2+. The relationship between redox signaling and Cxs attracts considerable attention in recent years. There is ample evidence showing that redox signaling molecules (e.g., hydrogen peroxide (H2O2), nitric oxide (NO)) affect Cxs-based channel function while the opening of Cx channels also triggers the transfer of various redox-related metabolites (e.g., reactive oxygen species, glutathione, nicotinamide adenine dinucleotide, and NO). On the basis of these evidences, we propose the existence of redox-Cxs crosstalk. In this review, we briefly discuss the interaction between redox signaling and Cxs and the implications of the intersection in disease pathology and future therapeutic interventions.Entities:
Keywords: Connexin; Disease pathology; Mutual interplay; Redox; Therapy
Mesh:
Substances:
Year: 2021 PMID: 33928434 DOI: 10.1007/s00109-021-02084-0
Source DB: PubMed Journal: J Mol Med (Berl) ISSN: 0946-2716 Impact factor: 4.599